Salsolinol (1), a tetrahydroisoquinoline alkaloid, was isolated from the marine sponge Xestospongia cf. vansoesti collected in Indonesia as a proteasome inhibitor, along with three salsolinol derivatives, norsalsolinol (2), cis-4-hydroxysalsolinol (3), and trans-4-hydroxysalsolinol (4). Compounds 1 and 2 inhibited the chymotrypsin-like activity of the proteasome with IC 50 values of 50 and 32 m mg/ml, respectively, but 3 and 4 showed no inhibitory effect even at 100 m mg/ml.
The proteasome functions as a proteolytic machine in the ubiquitin-dependent proteolytic pathway called the ubiquitinproteasome system. 1, 2) The 26S proteasome consists of two subcomplexes, the 20S core particle (the 20S proteasome) and the 19S regulatory particle, and a client protein is degraded by the proteolytic active sites of the 20S proteasome after polyubiquitination. The 20S proteasome is classified as a threonine protease that contains two pairs of three different sites, which catalyze chymotrypsin-like, trypsin-like, and caspase-like activities. Since the level of proteasome activity is increased especially in tumor cells, it is reasonable to develop specific compounds targeting the ubiquitin-proteasome system for cancer treatment. The recent approval of bortezomib (PS-341, Velcade ® ), a synthetic proteasome inhibitor, for the treatment of relapsed multiple myeloma has opened the way to the discovery of drugs targeting the proteasome. 3, 4) Significantly, bortezomib is effective against various tumor cells that are resistant to conventional chemotherapeutic agents. 5) Currently, three proteasome inhibitors, salinosporamide A (NPI-0052), [6] [7] [8] carfilzomib (PR-171), 9, 10) and CEP-18770, 11, 12) are undergoing phase I and II clinical trials. So far, structurally-diverse proteasome inhibitors have been developed by chemical synthesis and also by searching natural sources and chemical libraries as drugs for the clinical treatment of cancer and also as molecular tools for the investigation of cellular events. 13) During a search for natural products exhibiting biological activity, we screened extracts of natural sources for inhibitory activity against the proteasome. To date, based on the inhibition of the chymotrypsin-like activity of the proteasome, we isolated agosterols, 14) mycalolides, 15) cis-hinokiresiol, 16) and aaptamine derivatives 17) from natural sources as proteasome inhibitors. Here, we report the isolation of salsolinol (1) and its derivatives (2-4) from the marine sponge Xestospongia cf. vansoesti, and their two biological activities, inhibitory activity against the chymotrypsin-like activity of the proteasome and cytotoxic activity.
Specimens of Xestospongia cf. vansoesti were collected in Indonesia. The EtOH extract of the sponge was evaporated, and the aqueous residue was extracted with EtOAc and then n-BuOH. The n-BuOH (6.0 g) and H 2 O fractions, which showed inhibitory activity against the chymotrypsin-like activity of the proteasome and cytotoxicity, were subjected to octadecyl silyl (ODS) column chromatography and ODS HPLC to afford salsolinol (1, 191 November 18, 2010 43.9 (CH 2 ), which was supported by the FAB-MS spectrum. Thus, 2 was identified as 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (norsalsolinol).
19) The molecular formulas of the cis-(3) and trans-4-hydroxysalsolinols (4), C 10 H 13 NO 3 , were established by high resolution (HR)-FAB-MS and both isomers were found to contain an additional oxygen atom when compared to 1. Their NMR spectra were similar to those of 1, except for the absence of the methylene group in 1 and the presence of additional methine signals in the lower field in 3 and 4, d 4.77 (m) and 4.78 (m), respectively ( Table  1) . Analysis of 2D-NMR data indicated that 3 and 4 were 4-hydroxy derivatives of 1. Although 3 and 4 have yet to be isolated from natural sources, they have been chemically synthesized. 20) From the NMR data, 3 and 4, isolated from the sponge, were identified as cis and trans isomers, respectively. The specific rotation of 1, [a] D 0, indicated a racemic mixture, as confirmed by flat circular dichroism (CD) curves from 200 to 400 nm. The racemic character of 1 could be rationalized by considering its biosynthetic pathway (Chart 2), in which it is generated by the condensation of dopamine and acetaldehyde. On the other hand, 3 and 4 would be biosynthesized by the condensation of (Ϫ)-noradrenaline and acetaldehyde, and so have the 4R configuration (Chart 2). We prepared 3 and 4 from (Ϫ)-noradrenaline and measured the specific rotations. However, the values of the synthetic 3 and 4 were almost zero and we could not determine the absolute configurations on the basis of the values.
Thus, we isolated salsolinol (1), norsalsolinol (2), cis-4-hydroxysalsolinol (3), and trans-4-hydroxysalsolinol (4) from the marine sponge Xestospongia cf. vansoesti collected in Indonesia. Proteasome inhibitory and cytotoxic activities of 1 and 2 are listed in Table 2 . Compounds 1 and 2 inhibited the chymotrypsin-like activity of the proteasome with IC 50 values of 50 and 32 mg/ml, respectively, and also showed cytotoxicity against human cervix epithelioid carcinoma (HeLa) cells with IC 50 values of 17 and 7 mg/ml, respectively. Compounds 3 and 4 showed no proteasome inhibitory activity even at 100 mg/ml and no cytotoxicity against HeLa cells at 50 mg/ml. In addition, the cytotoxicity of 1 was tested against murine leukemia (L1210), human amnion (FL), human oral epidermoid carcinoma (KB), and human lung adenocarcinoma (A549) cell lines. The respective IC 50 values were 8, 13, 20, and 27 mg/ml.
Salsolinol (1) is detected in human and animal brains, and is thought to be synthesized from dopamine. 21) Kicha et al. isolated 1 as salts with steroidal sulfates from the starfish Lethasterias nanimensis chelifera, 18) and reported that the Risomer was predominantly incorporated into the salts. Liu et al. found the ratio of (R)-to (S)-1 to be 1.6 in the cerebral ganglion of Aplysia californica and 1.07 in a dried banana, by gas chromatography-mass spectrometry with cyclodextrin chiral columns. 22) In addition, 1 has been isolated from Asclepiadaceae, 23) Papaveraceae, 23) and Aristolochiaceae 24) plants. However, this is the first time that 1 has been isolated from a marine sponge and it should be noted that its yield, 0.048% (wet weight), is relatively high. As 2 was detected in dopamine-rich areas of the human brain 25, 26) and both 3 and 4 have been only chemically synthesized, 20) this is the first isolation of 2-4 as secondary metabolites from a natural source.
In mammalian brains, salsolinol (1) has neurotoxic effects in dopaminergic cells, and its metabolites, including its N- 
Proteasome inhibition was tested for the chymotrypsin-like activity with a 20S proteasome preparation from human erythrocytes (BostonBiochem, E-360). a) Not tested. methylated derivative N-methylsalsolinol, are implicated in the etiopathogenesis of Parkinson's disease. 21) In dopaminergic neuroblastoma SH-SY5Y cells, 1 causes both apoptosis and necrosis. 27) Despite its neurotoxic activity, 1 induces the release of prolactin from the anterior lobe of the pituitary gland by binding an unknown receptor, 21, 28) implying that it functions as a neuromodulator.
In this study, we first found that salsolinol (1) and its derivative (2) function as proteasome inhibitors. In connection with our findings, it should be noted that dopamine inhibits a chymotrypsin-like activity of purified human 20S proteasome. 29) Furthermore, it has been reported that lactacystin, a proteasome inhibitor, causes loss of nigral dopaminergic neurons. 30) Thus, it can be inferred that 1 induces dopaminergic neuron death possibly through the inhibition of the proteasome.
Experimental
Optical rotations were determined with a JASCO P-1020 polarimeter in H 2 O. CD spectra were measured on a JASCO J-720WI spectropolarimeter in MeOH. NMR spectra were recorded on a Bruker Avance 500 NMR spectrometer in CD 3 A voucher specimen (RMNH POR. 4807) has been deposited in the National Museum of Natural History, The Netherlands. The sponge (400 g, wet weight) was extracted with EtOH. The extract was evaporated, and the aqueous residue was extracted with EtOAc and then n-BuOH. The n-BuOH fraction (6.0 g) and H 2 O fraction showed inhibitory activity against the chymotrypsin-like activity of the proteasome and cytotoxicity. The n-BuOH fraction was partitioned between hexane and 90% MeOH-H 2 O, and the methanolic fraction (5.0 g) was subjected to ODS column chromatography with a step-wise gradient using H 2 O and MeOH. The fraction eluted with serum, penicillin (50 units/ml), and streptomycin (50 mg/ml) under a humidified atmosphere of 5% CO 2 at 37°C. The cells were seeded into 96-well microplates (3ϫ10 3 cells/well) and pre-cultured for 1 d. The medium was replaced with that containing test compounds at various concentrations and the cells were further cultured at 37°C for 3 d. The medium was then replaced with 50 ml of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) solution (0.2 mg/ml in medium) and the cells were incubated under the same conditions for 3 h. After the addition of 200 ml of dimethyl sulfoxide (DMSO), the optical density at 570 nm was measured with a microplate reader (MTP-810Lab, Corona Electric, Japan). Cytotoxicity against L1210, FL, KB, and A549 cells was tested according to the same procedure.
Proteasome Inhibition Assay The fluorogenic compound Suc-LeuLeu-Val-Tyr-MCA (Peptide Institute, Inc., Osaka, Japan) was used as a substrate for the chymotrypsin-like activity of the 20S proteasome preparation from human erythrocytes (BostonBiochem, E-360). The proteasome (0.5 nM) in a mixture (100 ml) that contained 50 mM Tris-HCl, pH 7.8, 1 mM dithiothreitol, 5 mM ethylenediaminetetraacetic acid (EDTA), and 0.02% sodium dodecyl sulfate (SDS) was pre-incubated with test compounds at various concentrations at 30°C for 10 min. Then, the substrate (10 mM) was added and the mixture was further incubated at 30°C for 16 h. The reaction was stopped by adding 100 ml of 10% SDS and the fluorescence intensity owing to 7-amino-4-methylcoumarin (AMC) was measured (excitation, 360 nm; emission, 450 nm) with the microplate reader. The IC 50 , the concentration required for 50% inhibition of the proteasome inhibitory activity, was calculated from duplicate measurements.
